Filtern
Erscheinungsjahr
- 2019 (2) (entfernen)
Dokumenttyp
- Vortrag (1)
- Posterpräsentation (1)
Sprache
- Englisch (2) (entfernen)
Referierte Publikation
- nein (2)
Organisationseinheit der BAM
Eingeladener Vortrag
- nein (1)
Background. Aflatoxin B1 (AFB1) is a toxic low-molecular-weight secondary fungal metabolite produced mainly by Aspergillus flavus and Aspergillus parasiticus not only at pre-harvest time but also at post-harvest stages including storage. AFB1 was classified as a Group I carcinogen by the World Health Organization for Research on Cancer in 1993. AFB1 is able to naturally contaminate medicinal plants and therefore causing serious health issues for humans consuming the related medicine. This study aimed to develop an efficient fluorescence polarization immunoassay (FPIA) and for the first time a rapid (5-10 min), low-cost, and simple membrane-based flow-through immunoassay (MBA) for determination of AFB1 in medical herbs based on a monoclonal antibody.
Methods. Two different techniques for AFB1detection in medical herbs (Herba Orígani vulgáris, Folia Urticae, Fructus Rubi idaei) were developed and compared, namely an easy-to-use semi-quantitative flow-through membrane-based enzyme immunoassay (MBA), and a homogeneous method which needs no separation or washing steps (assay time 10 min), a quantitative fluorescence polarization immunoassay (FPIA).
Results. A cut-off level of the developed MBA can vary wide from 0.8 ppb to 1 ppb. The FPIA method showed a linear working range of 8.6 ppb to 64 ppb, IC50 of FPIA is 24 ppb. The results were in good correlation with the ELISA results (IC50 = 0.1 ppb). LC–MS/MS was used to confirm the results, too.
Conclusion. MBA can be used for a quick on-site AFB1 detection in medical herbs (Herba Orígani vulgáris (Oríganum vulgáre), Folia Urticae (Urtíca dióica), Fructus Rubi idaei (Rúbus idáeus)), the developed test does not require special equipment and is not time-consuming (5-10min), includes several simple steps and can be performed directly on-site. The major advantages of the developed FPIA are its simplicity and suitability for a rapid screening of a large number of samples.
Bisphenol A (BPA) is a chemical that has been used in the production of plastics for more than 40 years. BPA released from bottles made of polycarbonates has been identified as a potential endocrine disrupting substance. Comprehensive research has been undertaken to test and verify its effect on animals and human beings.
Many methods have been proposed for the determination of BPA, in particular, gas and liquid chromatography. The main disadvantages of such approaches are the high cost of the equipment, the significant duration of an analysis, and difficulties in screening a large number of samples. Lateral Flow ImmunoAssay (LFIA) attributes are high throughput, high specificity and sensitivity, as well as low cost and simplicity.
An LFIA test strip was developed. This LFIA is based on anti-BPA antibodies (from mouse) conjugated with gold nanoparticles as the marker by passive absorption and covalent coupling, deposited in an elaborate pad. To form control and test zones, anti-mouse antibody and a BVA-BSA conjugate were spotted on the nitrocellulose membrane, respectively.
Negative samples are revealed by red lines both in the test and control zones, respectively, whereas positive samples produce a single red line only in the control zone. The measurement range is 0.05 – 23 μg/L, visually detected by the naked eye within 5 minutes. In addition, the intensities at the test line can be read by dedicated lateral flow readers (opTrilyzer® and Cube by opTricon, Berlin) for a more precise and documented determination.